ALLURION TECHNOLOGIES INC
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
ALUR$0.67-5.6%Stored close · as of Mar 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Deficit
UNAUDITED CONDENSED CONSOLIDATED STATEM ENTS OF STOCKHOLDERS’ DEFICIT
| Common Stock · Additional Paid- · Accumulated Other · Accumulated · Stockholders’ | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · in Capital · Comprehensive Loss · Deficit · Deficit | ||||||||||||||
| Balance as of January 1, 2023 | 27,079,856 | 3 | 99,875 | — | (132,192) | (32,314) | ||||||||
| Exercise of stock options | 15,376 | — | 20 | — | — | 20 | ||||||||
| Issuance of Legacy Allurion convertible preferred stock for the exercise of warrants | 3,554 | — | 29 | — | — | 29 | ||||||||
| Stock-based compensation expense | — | — | 409 | — | — | 409 | ||||||||
| Net loss | — | — | — | — | (17,801) | (17,801) | ||||||||
| Balance as of March 31, 2023 | 27,098,786 | 3 | 100,333 | — | (149,993) | (49,657) | ||||||||
| Exercise of stock options | 27,626 | — | 28 | — | — | 28 | ||||||||
| Issuance of Legacy convertible preferred stock for the exercise of warrants | 492 | — | 6 | — | — | 6 | ||||||||
| Stock-based compensation expense | — | — | 401 | — | — | 401 | ||||||||
| Net loss | — | — | (21,996) | (21,996) | ||||||||||
| Balance as of June 30, 2023 | 27,126,904 | 3 | 100,768 | — | (171,989) | (71,218) | ||||||||
| Balance as of January 1, 2024 | 47,688,096 | 5 | 143,007 | (700) | (212,799) | (70,487) | ||||||||
| Exercise of stock options | 4,646 | — | 9 | — | — | 9 | ||||||||
| Issuance of common stock for the exercise of Public Warrants | 142 | — | — | — | — | — | ||||||||
| Issuance of common stock from equity line financing (Note 12) | 143,234 | — | 378 | — | — | 378 | ||||||||
| Issuance of common stock in connection with vesting of RSU awards | 62,619 | — | — | — | — | — | ||||||||
| Stock-based compensation expense | — | — | 552 | — | — | 552 | ||||||||
| Other comprehensive loss | — | — | — | (2,200) | — | (2,200) | ||||||||
| Net income | — | — | — | — | 5,586 | 5,586 | ||||||||
| Balance as of March 31, 2024 | 47,898,737 | 5 | 143,946 | (2,900) | (207,213) | (66,162) | ||||||||
| Exercise of stock options | 11,491 | — | 16 | — | — | 16 | ||||||||
| Issuance of common stock in connection with vesting of RSU awards | 62,619 | — | — | — | — | — | ||||||||
| Issuance of common stock for the exercise of Public Warrants | 142 | — | 1 | — | — | 1 | ||||||||
| Stock-based compensation expense | — | — | 805 | — | — | 805 | ||||||||
| Other comprehensive loss | — | — | — | (3,080) | — | (3,080) | ||||||||
| Net loss | — | — | — | — | (2,162) | (2,162) | ||||||||
| Balance as of June 30, 2024 | 47,972,989 | 5 | 144,768 | (5,980) | (209,375) | (70,582) | ||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.